| Literature DB >> 29588777 |
Abstract
The Placement of Aortic Transcatheter Valves (PARTNER) trial showed the effectiveness of transcatheter aortic valve replacement (TAVR) for inoperable patients and non-inferiority for mortality versus open valve replacement. There are three questions concerning the role of TAVR for intermediate-risk patients. These relate to: institutional and surgeon results, physician and hospital alignments, and who will pay.Entities:
Keywords: Transcatheter aortic valve replacement; aortic valve replacement; aortic valve stenosis; transcatheter aortic valve implantation
Year: 2014 PMID: 29588777 PMCID: PMC5808517 DOI: 10.15420/icr.2011.9.1.41
Source DB: PubMed Journal: Interv Cardiol ISSN: 1756-1485